| Literature DB >> 35703011 |
Mingqian Li1, Fei Li2, Jiabin Chen1, He Su3, Guanping Chen1, Jili Cao1, Jiacheng Li2, Liyao Dong2, Zhihong Yu1, Yifan Wang1, Chun Zhou4, Yongqiang Zhu1, Qin Wei5, Qun Li2, Kequn Chai1.
Abstract
Protein signaling complexes play important roles in prevention of several cancer types and can be used for development of targeted therapy. The roles of signaling complexes of phosphodiesterase 3B (PDE3B) and Rap guanine nucleotide exchange factor 3 (RAPGEF3), which are two important enzymes of cyclic adenosine monophosphate (cAMP) metabolism, in cancer have not been fully explored. In the current study, a natural product Kaempferol-3-O-(3'',4''-di-E-p-coumaroyl)-α-L-rhamnopyranoside designated as KOLR was extracted from Cinnamomum pauciflorum Nees leaves. KOLR exhibited higher cytotoxic effects against BxCP-3 pancreatic cancer cell line. In BxPC-3 cells, the KOLR could enhance the formation of RAPGEF 3/ PDE3B protein complex to inhibit the activation of Rap-1 and PI3K-AKT pathway, thereby promoting cell apoptosis and inhibiting cell metastasis. Mutation of RAPGEF3 G557A or low expression of PDE3B inactivated the binding action of KOLR resulting in KOLR resistance. The findings of this study show that PDE3B/RAPGEF3 complex is a potential therapeutic cancer target.Entities:
Keywords: phosphodiesterase 3B; protein signaling complexes; rap guanine nucleotide exchange factor 3; signaling pathway; therapeutic cancer target
Mesh:
Substances:
Year: 2022 PMID: 35703011 DOI: 10.1002/ptr.7521
Source DB: PubMed Journal: Phytother Res ISSN: 0951-418X Impact factor: 6.388